The Trump stump
NEW YORK — In a slew of interviews in recent months with ABC News, Fox News, CNN and even the BBC, Donald Trump has made no secret of the fact that he’s seriously considering a presidential bid in 2012.
In an interview with ABC News correspondent George Stephanopoulos, Trump described himself as a Republican, and said that if he decided to run, it would be as a Republican. He added, “I’m going to make a decision probably by June.”
This isn’t the first time for Trump. He launched an exploratory committee in 1999 for a possible presidential bid as an independent candidate in 2000, and was mentioned as a possible running mate for George H.W. Bush in 1988. But he said his interest now is rooted in his alarm over the economy and the diminishment of America’s status in the world. “I’m looking at this country and what’s happened in terms of respect,” Trump told Stephanopoulos. Chinese business counterparts, he said, “laugh at us. They’re making the products we used to make in this country.”
Thus, Trump said he’d push for a more assertive stance with China, which he declared is gaining the upper hand in manufacturing and job creation. “The problem is our jobs have left this country,” Trump told Fox News host Greta Van Susteren. “Between China and other places, we just don’t make product anymore. … We’re losing our jobs to other countries, and you’re not going to solve unemployment unless something very, very stringent is done,” Trump said.
Trump’s solution: “I would tax Chinese products. People say, ‘That’s not free trade.’ We don’t have free trade now. We have a country … that is ripping us [off]” by manipulating its currency to make Chinese goods cheaper for American companies and consumers to buy than U.S. goods, he asserted.
An informal poll of Internet users who have visited ShouldTrumpRun.com found support for the idea. Of the nearly 30,000 people who have responded to the question, “Should Donald Trump enter the 2012 presidential race?” two-thirds (67%) have responded in the affirmative. An almost equal number (66%) of those who responded to the survey also indicated they would vote for him.
However, a poll on DrugStoreNews.com told an opposite story, with 75% of the 387 online users who voted saying a Trump presidency would be bad for retail pharmacy.
No comments found
Collaborative care alchemy: Pharmacists + nurses = gold
Last month, the American Journal of Managed Care published a review of more than 40 years worth of studies from various medical journals that demonstrated that the best way to improve adherence is to get patients to talk to the store pharmacist; the second-best way is to get them to talk to a nurse before they leave the hospital.
“There have been many studies on the subject of boosting adherence,” said William Shrank of Brigham and Women’s Hospital and Harvard University, who led the team of researchers that carried out the study, sponsored by CVS Caremark. “We decided it was important to review the total body of work to determine which communication channel had the greatest impact.”
In all, the study covered more than 6,500 journal articles published between 1966 and 2008. “These findings offer payers, healthcare providers and policy-makers guidance about how to develop programs that improve patient adherence,” CVS Caremark chief medical officer Troyen Brennan said.
As the clock ticks away toward full implementation of the Affordable Care Act in 2014, and with Republicans in the new Congress hell-bent on repealing or at least replacing the parts of it they don’t like — even if they can’t — there is going to be more attention paid to how all this extra health care is going to get paid for and what America is getting for its money. Fixing adherence is worth about one-third of the total cost of health reform.
Drug Store News has believed in the power of pharmacists and nurses to improve health care for several years. It was a key reason we added Retail Clinician magazine to The Drug Store News Group in 2006 — you didn’t have to be a fancy Harvard doctor to see that pharmacists and nurse practitioners working together in a collaborative care setting was going to be a big part of the future of health care in America. We wanted to help connect the dots between these two incredibly important groups of practitioners to help close the gaps in access and affordability in the U.S. healthcare system.
This year, we are taking that commitment to a new level. A new addition to the program at the fourth annual Retail Clinician Education Congress this August will feature a special day of Collaborative Care Track education, including six dually accredited continuing education sessions for pharmacists and nurse practitioners. The topics are targeted specifically to pharmacists and NPs practicing in a pharmacy/retail clinic environment. We want to help get these two critically important healthcare professionals closer together in the interest of driving better patient outcomes.
If you have retail clinics in any of your pharmacies, I strongly encourage you to send some of your key pharmacy managers to RCEC this year. Contact me at [email protected] if you need more information.
No comments found
Kinray’s Stewart Rahr has a vision for America… Is it good for your business?
WHITESTONE, N.Y. — Business mogul, real-estate developer on a colossal scale with an ego to match, reality TV star, highest of the high-profile billionaires. Could Donald Trump’s next big role be president of the United States?
More importantly, would Trump the president be good for the country and, more specifically, for retail and wholesale pharmacy?
Stewart Rahr, fresh from the sale of the drug distribution business that propelled him into Trump’s stratospheric income bracket, clearly thinks so. Rahr, who owned and led Whitestone, N.Y.-based Kinray until its sale last fall to Cardinal Health, is putting his considerable energy and some of his own money into a determined campaign to convince Trump, his pal and occasional golfing partner, to run for the Republican presidential nomination in 2012 — and to deny President Obama a second term.
“He’d be an amazing president, as I see it, because he possesses the attributes the country needs as a president,” Rahr enthused in a mid-December interview with Drug Store News. “He’s intelligent and a tremendous negotiator. He’s a leader in every sense of the word, and he loves America.”
Rahr speaks with the sunny optimism and passion of a true convert, and the restless energy of the self-made billionaire, philanthropist and social dynamo he has become in the past three decades.
In an office whose walls are covered with photos of Hollywood celebrities and sports stars he calls friends, behind a desk covered with his trademark yellow sunglasses, Rahr, now approaching his mid-60s, still is on constant simmer.
Lately, the self-described “King of all Fun” is focused on what he sees as a high calling: the effort to put Trump into national office. “I’m devoting a lot of time trying to convince Donald that he’d make a good president,” Rahr told DSN.
Among other actions, Rahr has lent his support to a new website, ShouldTrumpRun.com, and issued a statement to solicit input and support for a presidential bid by his friend. In that solicitation, he called Trump “a natural born leader with outstanding ability to inspire others and to accomplish impossible tasks.” He also cited a poll from NewsMax.com to assert that Trump could win in a head-to-head contest versus President Obama. “Please join me in trying to convince Donald to consider running for this high office,” Rahr told supporters. “This is as serious as I get,” he added.
Rahr described Trump as “a social moderate” who would aggressively promote America’s return to undisputed global economic leadership. “Donald doesn’t like being second to China or to India,” he asserted. “He’s a visionary, and he thinks forward. He’d love to bring jobs back to America, and ensure that every American has a job. We need a businessperson … [who] can surround himself with the brightest intellectual minds and get things done.”
What would a Trump presidency mean for retail and wholesale pharmacy? Rahr asserted the billionaire “would be a great champion for our industry. … He doesn’t like the Obama healthcare plan,” the executive said. “He thinks there’s too many holes in it, it doesn’t take care of everyone and it’s too expensive. As for the pharmaceutical industry, as long as the product is made in America, he’d support it because that creates revenues and employs Americans,” Rahr said. “He’ll be a friend of this industry, as long as it would be made or distributed here in the United States and not elsewhere.”
A Trump presidency also would benefit from its ties to the former Kinray leader, Rahr said. “With [my background in] the pharmaceutical industry, certainly we’d have an ear to explain the problems we have as manufacturers and as distributors, in health care and pharmacies especially. … I am who I am today because of the pharmaceutical business.”
Rahr predicted his friend likely will make a decision over the next few months — and may begin campaigning in earnest by May or June. “I think it’s going to happen,” he confidently stated.
I had the honor of working with Kinray employee's in the distribution a new generic Rx oral rinse. I found the Kinray employee's to be a very determined, professional and a result-oriented team under Stewart Rahr's leadership. In fact, I was also honored to witness and hear the story on how Stewart Rahr personally saved the famous 9-11 Ground Zero photograph autographed by the three fireman raising the American Flag by outbidding parties outside the United States. Stewart Rahr has a Servant Leadership reputation. He's demonstrated concerned about the welfare his employee's and our industry. I believe his support of Donald Trump is an indication of his desire to improve the quality and strength of U.S. leadership at home and around the world. I support Stewart Rahr's goal of getting Donald Trump to run for President. We have too many lawyers in Washington D.C.---we need experienced business executives to put America back on course. Hal Burke National Accounts Manager Xttrium Laboratories 773-268-5800 (Ext. 160) [email protected]